Dr. Hop Tran Cao, MD
Claim this profileM D Anderson Cancer Center
Studies Cholangiocarcinoma
Studies Bile Duct Cancer
3 reported clinical trials
5 drugs studied
Area of expertise
1Cholangiocarcinoma
Stage II
Stage I
2Bile Duct Cancer
Stage II
Stage I
Affiliated Hospitals
Clinical Trials Hop Tran Cao, MD is currently running
Pembrolizumab + Chemotherapy
for Bile Duct Cancer
To find out if adding pembrolizumab to standard of care chemotherapy drugs (cisplatin and gemcitabine) will improve long-term response of intrahepatic cholangiocarcinoma after surgery, compared to treatment with surgery and standard chemotherapy alone.
Recruiting1 award Phase 2
Durvalumab + Chemotherapy
for Bile Duct Cancer
This phase II trial tests how well giving durvalumab with standard chemotherapy, gemcitabine and cisplatin, before surgery works in treating patients with high risk liver cancer (cholangiocarcinoma) that can be removed by surgery (resectable). Durvalumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as gemcitabine and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving durvalumab with gemcitabine and cisplatin before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed in patients with high risk resectable cholangiocarcinoma.
Recruiting1 award Phase 2
More about Hop Tran Cao, MD
Clinical Trial Related1 year of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Hop Tran Cao, MD has experience with
- Cisplatin
- Gemcitabine
- Pembrolizumab
- Questionnaires
- Durvalumab
Breakdown of trials Hop Tran Cao, MD has run
Cholangiocarcinoma
Bile Duct Cancer
Liver Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Hop Tran Cao, MD specialize in?
Hop Tran Cao, MD focuses on Cholangiocarcinoma and Bile Duct Cancer. In particular, much of their work with Cholangiocarcinoma has involved Stage II patients, or patients who are Stage I.
Is Hop Tran Cao, MD currently recruiting for clinical trials?
Yes, Hop Tran Cao, MD is currently recruiting for 3 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Hop Tran Cao, MD has studied deeply?
Yes, Hop Tran Cao, MD has studied treatments such as Cisplatin, Gemcitabine, Pembrolizumab.
What is the best way to schedule an appointment with Hop Tran Cao, MD?
Apply for one of the trials that Hop Tran Cao, MD is conducting.
What is the office address of Hop Tran Cao, MD?
The office of Hop Tran Cao, MD is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.